Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

S. Stenning · SciRah

Researcher profile · Semantic Scholar

S. Stenning

Share profile

S. Stenning — researcher profile on SciRah

h-index: 53
Works: 208
Citations: 18K

Most-cited papers

Long-term results of a randomized trial of surgery with or without preoperative chemotherapy in esophageal cancer.
W. Allum, S. Stenning, J. Bancewicz, P. Clark +1 more
2009Journal of Clinical Oncology962 citations
Semantic Scholar
Mismatch Repair Deficiency, Microsatellite Instability, and Survival: An Exploratory Analysis of the Medical Research Council Adjuvant Gastric Infusional Chemotherapy (MAGIC) Trial
E. Smyth, A. Wotherspoon, C. Peckitt, D. Gonzalez +12 more
2017JAMA Oncology496 citations Open access
Semantic Scholar
Strategies to improve retention in randomised trials
Valerie Brueton, J. Tierney, S. Stenning, S. Harding +3 more
2013Cochrane Database of Systematic Reviews339 citations Open access
Semantic Scholar
Randomized trial of carboplatin versus radiotherapy for stage I seminoma: mature results on relapse and contralateral testis cancer rates in MRC TE19/EORTC 30982 study (ISRCTN27163214).
R. Oliver, G. Mead, G. Rustin, J. Joffe +5 more
2011Journal of Clinical Oncology275 citations
Semantic Scholar
Peri-operative chemotherapy with or without bevacizumab in operable oesophagogastric adenocarcinoma (UK Medical Research Council ST03): primary analysis results of a multicentre, open-label, randomised phase 2–3 trial
David Cunningham, S. Stenning, Elizabeth C. Smyth, A. Okines +14 more
2017The Lancet Oncology270 citations Open access
Semantic Scholar
Temozolomide versus procarbazine, lomustine, and vincristine in recurrent high-grade glioma.
M. Brada, S. Stenning, R. Gabe, L. Thompson +9 more
2010Journal of Clinical Oncology244 citations Open access
Semantic Scholar
Strategies to improve retention in randomised trials: a Cochrane systematic review and meta-analysis
Valerie Brueton, J. Tierney, S. Stenning, S. Meredith +3 more
2014BMJ Open240 citations Open access
Semantic Scholar
A prospective clinicopathologic study of dose-modified CODOX-M/IVAC in patients with sporadic Burkitt lymphoma defined using cytogenetic and immunophenotypic criteria (MRC/NCRI LY10 trial).
G. Mead, S. Barrans, W. Qian, J. Walewski +6 more
2008Blood227 citations Open access
Semantic Scholar
Randomized trial of two or five computed tomography scans in the surveillance of patients with stage I nonseminomatous germ cell tumors of the testis: Medical Research Council Trial TE08, ISRCTN56475197--the National Cancer Research Institute Testis Cancer Clinical Studies Group.
G. Rustin, G. Mead, S. Stenning, P. Vasey +6 more
2007Journal of Clinical Oncology215 citations
Semantic Scholar
Neoadjuvant cisplatin and fluorouracil versus epirubicin, cisplatin, and capecitabine followed by resection in patients with oesophageal adenocarcinoma (UK MRC OE05): an open-label, randomised phase 3 trial
D. Alderson, D. Cunningham, M. Nankivell, J. Blazeby +13 more
2017The Lancet Oncology210 citations Open access
Semantic Scholar
Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal carcinoma treatment (ICON8): primary progression free survival analysis results from a GCIG phase 3 randomised controlled trial
A. Clamp, E. James, I. McNeish, A. Dean +25 more
2019The Lancet161 citations Open access
Semantic Scholar
18fluorodeoxyglucose positron emission tomography in the prediction of relapse in patients with high-risk, clinical stage I nonseminomatous germ cell tumors: preliminary report of MRC Trial TE22--the NCRI Testis Tumour Clinical Study Group.
R. Huddart, M. O'Doherty, A. Padhani, G. Rustin +10 more
2007Journal of Clinical Oncology146 citations
Semantic Scholar
Randomized trials in 2466 patients with stage I seminoma: patterns of relapse and follow-up.
G. Mead, S. Fosså, R. Oliver, J. Joffe +5 more
2011Journal of the National Cancer Institute116 citations Open access
Semantic Scholar
Second cancer risk and mortality in men treated with radiotherapy for stage I seminoma
A. Horwich, S. D. Fosså, R. Huddart, D. Dearnaley +4 more
2013British Journal of Cancer99 citations Open access
Semantic Scholar
Rates of inclusion of teenagers and young adults in England into National Cancer Research Network clinical trials: Report from the National Cancer Research Institute (NCRI) Teenage and Young Adult Clinical Studies Development Group
L. Fern, S. Davies, T. Eden, R. Feltbower +7 more
2008British Journal of Cancer94 citations Open access
Semantic Scholar
Effect of HER2 on prognosis and benefit from peri-operative chemotherapy in early oesophago-gastric adenocarcinoma in the MAGIC trial.
A. Okines, L. Thompson, D. Cunningham, A. Wotherspoon +7 more
2013Annals of Oncology91 citations Open access
Semantic Scholar
Neoadjuvant chemotherapy for resectable oesophageal and junctional adenocarcinoma: Results from the UK Medical Research Council randomised OEO5 trial (ISRCTN 01852072).
D. Alderson, R. E. Langley, M. Nankivell, J. Blazeby +13 more
201590 citations
Semantic Scholar
Consolidation radiotherapy in patients with advanced Hodgkin's lymphoma: survival data from the UKLG LY09 randomized controlled trial (ISRCTN97144519).
P. Johnson, M. Sydes, B. Hancock, M. Cullen +2 more
2010Journal of Clinical Oncology83 citations Open access
Semantic Scholar
The potential for central monitoring techniques to replace on-site monitoring: findings from an international multi-centre clinical trial
J. Bakobaki, M. Rauchenberger, Nicola Joffe, S. McCormack +2 more
2012Clinical Trials76 citations
Semantic Scholar
Pediatric and Adolescent Extracranial Germ Cell Tumors: The Road to Collaboration.
T. Olson, M. Murray, C. Rodríguez-Galindo, J. Nicholson +26 more
2015Journal of Clinical Oncology73 citations Open access
Semantic Scholar
Bevacizumab with peri-operative epirubicin, cisplatin and capecitabine (ECX) in localised gastro-oesophageal adenocarcinoma: a safety report.
A. Okines, R. E. Langley, L. Thompson, S. Stenning +18 more
2013Annals of Oncology68 citations Open access
Semantic Scholar
ICON8: A GCIG phase III randomised trial evaluating weekly dosedense chemotherapy integration in first- line epithelial ovarian/fallopian tube/primary peritoneal carcinoma (EOC) treatment: Results of primary progression- free survival (PFS) analysis
A. Clamp, I. McNeish, A. Dean, D. Gallardo +15 more
201762 citations Open access
Semantic Scholar
Biomarker analysis in oesophagogastric cancer: Results from the REAL3 and TransMAGIC trials.
A. Okines, D. D. de Castro, D. Cunningham, I. Chau +23 more
2013European Journal of Cancer44 citations
Semantic Scholar
Imaging Modality and Frequency in Surveillance of Stage I Seminoma Testicular Cancer: Results From a Randomized, Phase III, Noninferiority Trial (TRISST)
J. Joffe, F. Cafferty, L. Murphy, G. Rustin +36 more
2022Journal of Clinical Oncology42 citations Open access
Semantic Scholar
A Randomised Phase 2 Trial of Intensive Induction Chemotherapy (CBOP/BEP) and Standard BEP in Poor-prognosis Germ Cell Tumours (MRC TE23, CRUK 05/014, ISRCTN 53643604)
R. Huddart, R. Gabe, F. Cafferty, P. Pollock +4 more
2011European Urology37 citations Open access
Semantic Scholar
Strategies to reduce attrition in randomised trials
Valerie Brueton, G. Rait, J. Tierney, S. Meredith +4 more
2011Trials33 citations Open access
Semantic Scholar
Prognostic and predictive markers in recurrent high grade glioma; results from the BR12 randomised trial
V. Collins, K. Ichimura, Ying Di, D. Pearson +5 more
2014Acta Neuropathologica Communications32 citations Open access
Semantic Scholar
UK management practices in stage I seminoma and the Medical Research Council Trial of Imaging and Schedule in Seminoma Testis managed with surveillance.
F. Cafferty, R. Gabe, R. Huddart, G. Rustin +7 more
2012Clinics in oncology29 citations
Semantic Scholar
2201 Peri-operative chemotherapy ± bevacizumab for resectable gastro-oesophageal adenocarcinoma: Results from the UK Medical Research Council randomised ST03 trial (ISRCTN 46020948)
D. Cunningham, E. Smyth, S. Stenning, L. Stevenson +16 more
201528 citations Open access
Semantic Scholar
Best practice guidance for the use of strategies to improve retention in randomized trials developed from two consensus workshops
Valerie Brueton, S. Stenning, F. Stevenson, J. Tierney +1 more
2017Journal of Clinical Epidemiology27 citations Open access
Semantic Scholar
Defining a New Prognostic index for Stage I Non-seminomatous Germ Cell Tumors using CXCL12 Expression and Proportion of Embryonal Carcinoma
D. Gilbert, R. Al-Saadi, K. Thway, I. Chandler +6 more
2015Clinical Cancer Research27 citations Open access
Semantic Scholar
Use of strategies to improve retention in primary care randomised trials: a qualitative study with in-depth interviews
Valerie Brueton, F. Stevenson, C. Vale, S. Stenning +5 more
2014BMJ Open27 citations Open access
Semantic Scholar
Triggered or routine site monitoring visits for randomised controlled trials: results of TEMPER, a prospective, matched-pair study
S. Stenning, William J. Cragg, Nicola Joffe, C. Diaz-Montana +3 more
2018Clinical Trials25 citations Open access
Semantic Scholar
Relapse patterns in 2,466 stage 1 seminoma patients (pts) entered into Medical Research Council randomised trials
G. Mead, S. D. Fosså, R. T. Oliver, P. Fogarty +3 more
200820 citations
Semantic Scholar
Safety and Efficacy of the Addition of Lapatinib to Perioperative Chemotherapy for Resectable HER2-Positive Gastroesophageal Adenocarcinoma
E. Smyth, S. Rowley, F. Cafferty, W. Allum +16 more
2019JAMA Oncology18 citations Open access
Semantic Scholar
Long term results of the MRC OEO2 randomized trial of surgery with or without preoperative chemotherapy in resectable esophageal cancer
W. Allum, P. Fogarty, S. Stenning, R. Langley +1 more
200817 citations
Semantic Scholar
Biopsy proportion of tumour predicts pathological tumour response and benefit from chemotherapy in resectable oesophageal carcinoma: results from the UK MRC OE02 trial
Matthew D. Hale, M. Nankivell, G. Hutchins, S. Stenning +10 more
2016OncoTarget16 citations Open access
Semantic Scholar
ST03: A randomized trial of perioperative epirubicin, cisplatin plus capecitabine (ECX) with or without bevacizumab (B) in patients (pts) with operable gastric, oesophagogastric junction (OGJ) or lower oesophageal adenocarcinoma.
E. Smyth, R. Langley, S. Stenning, L. Stevenson +16 more
201216 citations
Semantic Scholar
A systematic search for reports of site monitoring technique comparisons in clinical trials
J. Bakobaki, Nicola Joffe, S. Burdett, J. Tierney +2 more
2012Clinical Trials14 citations
Semantic Scholar
Socio-economic inequalities in testicular cancer survival within two clinical studies.
U. Nur, B. Rachet, M. Parmar, M. Sydes +6 more
2012Cancer Epidemiology13 citations Open access
Semantic Scholar
Pharmacogenetic analysis of the UKMRC (Medical Research Council) MAGIC trial: association of polymorphisms with toxicity and survival in patients treated with perioperative epirubicin, cisplatin and 5-fluorouracil (ECF) chemotherapy
E. Smyth, Shenli Zhang, D. Cunningham, A. Wotherspoon +11 more
2017Clinical Cancer Research12 citations Open access
Semantic Scholar
Preliminary safety data from a randomized trial of perioperative epirubicin, cisplatin plus capecitabine (ECX) with or without bevacizumab (B) in patients (pts) with gastric or oesophagogastric junction (OGJ) adenocarcinoma.
A. Okines, R. Langley, F. Cafferty, S. Stenning +6 more
201012 citations
Semantic Scholar
Adolescents and Young Adults With a “Rare” Cancer: Getting Past Semantics to Optimal Care for Patients With Germ Cell Tumors
Sara Stoneham, J. Hale, C. Rodríguez-Galindo, H. Dang +14 more
2018The Oncologist11 citations Open access
Semantic Scholar
Reduced genomic tumor heterogeneity after neoadjuvant chemotherapy is related to favorable outcome in patients with esophageal adenocarcinoma
Askar Obulkasim, B. Ylstra, H. V. van Essen, C. Benner +10 more
2016OncoTarget11 citations Open access
Semantic Scholar
LBA-03Neoadjuvant chemotherapy for resectable oesophageal and junctional adenocarcinoma: results from the UK Medical Research Council randomised OEO5 trial (ISRCTN 01852072)
D. Cunningham, R. Langley, M. Nankivell, J. Blazeby +13 more
201511 citations Open access
Semantic Scholar
Initial dose intensity has limited impact on the outcome of ABVD chemotherapy for advanced Hodgkin lymphoma (HL): data from UKLG LY09 (ISRCTN97144519).
Waheeda Owadally, M. Sydes, J. Radford, B. Hancock +3 more
2007Annals of Oncology11 citations Open access
Semantic Scholar
Long-term outcomes with intensive induction chemotherapy (carboplatin, bleomycin, vincristine and cisplatin/bleomycin, etoposide and cisplatin) and standard bleomycin, etoposide and cisplatin in poor prognosis germ cell tumours: A randomised phase II trial (ISRCTN53643604)
F. Cafferty, J. White, J. Shamash, I. Hennig +2 more
2020European Journal of Cancer10 citations Open access
Semantic Scholar
Dynamic methods for ongoing assessment of site-level risk in risk-based monitoring of clinical trials: A scoping review
William J. Cragg, C. Hurley, V. Yorke-Edwards, S. Stenning
2020medRxiv9 citations Open access
Semantic Scholar
Risk of second cancers among a cohort of 2,703 long-term survivors of testicular seminoma treated with radiotherapy.
A. Horwich, S. D. Fosså, S. Stenning, J. Bliss +1 more
20109 citations
Semantic Scholar
Imaging modality and frequency in surveillance of stage I seminoma testicular cancer: Results from a randomized, phase III, factorial trial (TRISST).
J. Joffe, F. Cafferty, L. Murphy, G. Rustin +15 more
2021Journal of Clinical Oncology8 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

R. Langley×13
Invite
R. Langley — researcher profile on SciRah
W. Allum×11
Invite
W. Allum — researcher profile on SciRah
D. Cunningham×11
Invite
D. Cunningham — researcher profile on SciRah
R. Huddart×11
Invite
R. Huddart — researcher profile on SciRah

×10

Invite

A. Okines — researcher profile on SciRah

Invite

R. Gabe — researcher profile on SciRah

Invite

S. Meredith — researcher profile on SciRah

Invite

F. Coxon — researcher profile on SciRah

Invite

H. Grabsch — researcher profile on SciRah

Invite

F. Cafferty — researcher profile on SciRah

M. Nankivell×6

Invite

M. Nankivell — researcher profile on SciRah

Invite

J. Tierney — researcher profile on SciRah